ICH Q2B C 74 3. Detection limit The ICH guideline on validation has been succeeded by the ICH guidelines on Impurities in New drug substances and Drug Products. In accordance with the Rules and Procedures of the 2015-2020 Council of Experts, the If the maximum amount of aluminum in SVIs and PBPs is 25 µg per L or less, instead of stating the exact amount of aluminum that each may contain, as in paragraph (d), the immediate container label for SVIs and PBPs used in the preparation or in the administration of TPN injections (with exceptions as noted below) and injectable emulsions may state: “Contains no more than 25 µg/L of aluminum”. The intention is to address the basic considerations needed for a successful transfer in order to satisfy the regulatory authority defi ned for the transfer process. endstream endobj startxref The purpose of this new codification is to ensure that the numbering / coding of ICH Guidelines is more logical, consistent and clear. ICH guideline Q4B Annex 3 on evaluation and recommendation of pharmacopoeial texts for use in the ICH regions on test for particulate contamination: sub- ... JP 6.07 Insoluble Particulate Matter Test for Injections, and USP <788> Particulate Matter in Injections General Chapter can be used as interchangeable in the ICH regions given the This Guideline has been developed by the appropriate ICH Expert Working Group and has been subject to consultation by the regulatory parties, in accordance with the ICH … injectable solutions. Injections and Implanted Drug Products (Parenterals)—Product Quality Tests Type of Posting Revision Bulletin Posting Date 25–Mar–2016 Official Date 01–May–2016 Expert Committee General Chapters—Dosage Forms Reason for Revision Compliance . ICH Harmonised Tripartite Guideline [EMEA Status as of December 1993] Preamble The following guideline sets out the stability testing requirement for a Registration Application within the three areas of the EC, Japan and the USA. CPMP/ICH/142/95 2/11 IMPURITIES IN NEW DRUG SUBSTANCES ICH Harmonised Tripartite Guideline [EMEA Status as of May 1995] 1. It does not cover the information to be submitted for abbreviated or abridged applications, variations and clinical trial applications. h�bbd``b`1 k���`����� ��$�W4�h�b`b�u�``$���E�@� �� Annex 4 89 prescribe a process for establishing hold times, but reflects aspects that should be considered in the design of the hold‑time study. Guideline for Bioequivalence Studies of Generic Products Index Section 1: Introduction Section 2: Terminology Section 3: Tests A. guideline). Guidance for Investigators - Comparison of ICH and FDA regulations Page 1 of 5 SEQuR - Guidance for Investigators – Comparison of ICH and FDA regulations Effective Date 10/01/2010 Supersedes NA The ICH guideline published May 9, 1997 in the Federal Register and has bee adopted as guidance in the US. Revised ICH (International Conference on Hormonisation) Quality Guidelines in pharmaceuticals are given below: Q1A (R2) – Stability Testing of New Drug Substances and Products Q1 B – Stability Testing : Photo Stability Testing of New Drug Substances and Products Q1C – Stability Testing for New Dosage Forms Q1D – Bracketing and Matrixing Designs for Stability Testing of New … Injectable Solutions Injectable solutions are those products in which the drug, any added excipients, and any added co-solvents all truly dissolve in the vehicle (usually water). h�bbd``b`���A� � Parent Guideline dated 27 October 1994 (Complementary Guideline on Methodology dated 6 November 1996 incorporated in November 2005) This Guideline has been developed by the appropriate ICH Expert Working Group and has been subject to consultation by the regulatory parties, in accordance with the ICH … Revised ICH (International Conference on Hormonisation) Quality Guidelines in pharmaceuticals are given below: Q1A (R2) – Stability Testing of New Drug Substances and Products Q1 B – Stability Testing : Photo Stability Testing of New Drug Substances and Products Q1C – Stability Testing for New Dosage Forms Q1D – Bracketing and Matrixing Designs for … Ich guidelines 1. This document defines the stability data package for a new drug substance or drug product that is sufficient for a registration application within the ICH regions. 2.2 The guidelines w ill be appl ied to manufactur ing act ive pharmaceut ical ingredients (APIs), manufacturing and packaging of … 3516 0 obj <>/Filter/FlateDecode/ID[<5F31A73C4F95EF4CB3E6A68632667690>]/Index[3506 23]/Info 3505 0 R/Length 67/Prev 419646/Root 3507 0 R/Size 3529/Type/XRef/W[1 2 1]>>stream ICH stability guidelines for stability conditions and testing are followed throughout the world for product quality. Classification of Impurities 2 3. Generally one lot can be used for validating hold times if any inconsistency results were observed then another two lots can be used for this study. ICH HARMONISED GUIDELINE. The velocity at … I. MPURITIES. In November 2005, the ICH Steering Committee adopted a new codification system for ICH Guidelines. WHO has issued a number of evidence-based recommendations to support the implementation of these strategies for safe injection practice. products are having all guidelines like ICH, USFDA, EMEA, WHO and etc. It does not cover the information to be submitted for abbreviated or abridged applications, variations and clinical trial applications. endstream endobj 234 0 obj <>/AGFA_NORN_V(ES15.101 V03)/AGFA_PSE_V(Apogee Norm PSE 1.1 23 )/AcroForm 242 0 R/JT 222 0 R/Metadata 157 0 R/PageMode/UseThumbs/Pages 211 0 R/Type/Catalog>> endobj 235 0 obj <> endobj 236 0 obj <>stream Hold time study data shall give the assurance the maximum allowable hold times for bulk and in-process drug products. Major Test methods 1) Design 2) Number of subjects 3) Selection of subjects 4) Drug administration a. ICH Harmonised Tripartite Guideline [EMEA Status as of December 1993] Preamble The following guideline sets out the stability testing requirement for a Registration Application within the three areas of the EC, Japan and the USA. �hh�xG�_����}�����+���8�U"�%v�M�T�Ю��g0QY��F#M���h��!�h&�eR\~98�Zo�W�����f��cK��U�Da���&. Guidelines on packaging for pharmaceutical products Introductory note 120 Glossary 121 1. 2.3.6 International Conference on Harmonisation (ICH) 12 2.3.7 Specific Safety Issues 13 2.3.8 Concluding Comments on the Regulatory Assessment 14 2.4 Manufacturing and Packaging 14 2.4.1 Process Capability and Validation 15 2.4.2 Test Methods and Validation 16 2.5 Excipient Specifications 17 2.5.1 Excipient Stability 17 3. %%EOF PREAMBLE This document is intended to provide guidance for registration applications on the content and ICH draft guidance, Q6A Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances, addresses … This guideline should be read in conjunction with the Annex I of Directive 2001/83/EC as amended, as well as European and ICH guidelines for conducting clinical trials, including those on: − General Considerations for Clinical Tr ials (ICH topic E8, CPMP/ICH/291/95) − Guideline for Good Clinical Practice (ICH E6 (R1), CPMP/ICH/135/95) This document is not intended to . �� 9W荤��5_��}��y%�r�����*�.Z/�R`�h�GiW�FI�^�Ŭ�ħ J�H��['xP|g�� 3�̜9{��9�'O���u�.Ȓ�(�P�E��V2�rD�xF,b �:���(�i����v����څR�@�M�\+�NX�겦թIK5EK(����3�D����'Q��'�hpuٛ�� ���j����M��f�i��m�[�N\1��û�(#��Ip�t������Z"�@C_+�r��R=b��'�6^�t���B�`Hvt00p P 233 0 obj <> endobj 6. Also, as part of the CTD guideline, the ICH process has produced recommendations for a Quality Overall Summary (QOS) (Module 2) which is a summary that follows the scope and the outline of the Quality Module (Module 3). Guidelines on packaging for pharmaceutical products Introductory note 120 Glossary 121 1. ]�"]Ҹݤq�rC`Y T� ICH GUIDELINES 2. Preamble 2 2. Q3D(R1) Final version Adopted on 22 March 2019 This Guideline has been developed by the appropriate ICH Expert Working Group and has been subject to consultation by the regulatory parties, in accordance with the ICH Process. 252 0 obj <>stream h�b```f``��������A�X��� \�-���)�)��2�F�P�iLj�����2�g���������y�7S� ��˴�)��K4s SC S�1S�g��'����R3�RS�ӧ�������20H��7n��.� WY! CPMP/ICH/142/95 1/11 IMPURITIES IN NEW DRUG SUBSTANCES ICH Harmonised Tripartite Guideline TABLE OF CONTENTS 1. ICH is the “International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use”. Oral immediate release products and enteric-coated products I. IMPURITIES: GUIDELINE FOR RESIDUAL SOLVENTS. G. UIDELINE FOR . Ich guidelines 1. �� 18:�$s�d�@��3:P�4P$�:@$�'ҁ����D� +��ˁā`v�- Injection Safety evidence, guidelines and publications. Quantitation limit, 4. 0 Aspects of packaging 125 1.1 General considerations 125 1.2 Functions of packaging 127 1.2.1 Containment 127 1.2.2 Protection 127 1.3 Presentation and information 129 1.3.1 Labels 129 1.3.2 Repacking, relabelling and dispensing 130 Guidance for Investigators - Comparison of ICH and FDA regulations Page 1 of 5 SEQuR - Guidance for Investigators – Comparison of ICH and FDA regulations Effective Date 10/01/2010 Supersedes NA The ICH guideline published May 9, 1997 in the Federal Register and has bee adopted as guidance in the US. 1.2 Background The parent guideline notes that the use of matrixing and bracketing can be applied, if justified, to the testing of new drug substances and products, but provides no further guidance on the subject. ���@�, ���6Jj�� (CPMP/ICH/4106/00) TRANSMISSION TO CPMP July 2000 RELEASE FOR CONSULTATION July 2000 DEADLINE FOR COMMENTS September 2000 SUBMISSION TO CPMP FOR INFORMATION November 2000 RELEASE FOR INFORMATION November 2000 Note: Date for coming into operation for this guideline will be released by the European Commission, h��W[o�6��z�0tG7K2Pp�I��]����h�%���q�yt���E6}Z�ṓ�����e[��Y���\�?�܁��k��Zn�؉,?0��5����A�� E. LEMENTAL . this guidance, but should be performed in accordance with GMP guidelines for drug (medicinal) products as defined by local authorities. %PDF-1.6 %���� FDA Guideline on Sterile Drug Products Produced by Aseptic Processing (1987): Normally, integrity testing of the filter is performed after the filter unit is assembled and prior to use. Regulatory Public Consultation of ICH Guidelines Step 2 of the ICH process is reached when the ICH Steering Committee agrees, based on the report of the EWG, that there is sufficient consensus on the technical issues for the draft guideline or recommendation to proceed to … Following is the list of ICH guidelines for stability testing: Q1A(R2) - Stability Testing of New Drug Substances and Products: This guidance is for analysis of the product for its stability in different environmental conditions. These policies, guidelines and best practice documents are available for download by … • Prefilled syringe containing an injectable drug suspension Injections and Implanted Drug Products (Parenterals)—Product Quality Tests Type of Posting Revision Bulletin Posting Date 25–Mar–2016 Official Date 01–May–2016 Expert Committee General Chapters—Dosage Forms Reason for Revision Compliance . n3�2饨1>� ��˨������&a�!&NH 3528 0 obj <>stream Mf`�m�X��t ICH guidance for industry Q3C Impurities: Residual Solvents (December 2017) (ICH Q3C). The available information was reviewed to establish the oral, parenteral and inhalation PDEs. "6 -' ��H�g`bd� ��&�3��` Ù� A suitable substance or mixture of substances to prevent the growth of microorganisms must be added to preparations intended for injection that are packaged in multiple-dose containers, regardless of the method of sterilization employed, unless one of the following conditions prevails: (1) there are different directions in the individual monograph; (2) the substance contains a … guidelines. in the Visual Inspection of Injectable Products John G. Shabushnig, Ph.D. Pfizer Global Quality Operations March 9, 2011 ©2011 This Guide covers APIs that are manufactured by chemical synthesis, extraction, cell culture/fermentation, by recovery from natural sources, or by any combination of these processes. This type of presentation is the most common of the injectable drug products, and … Q3C(R6) Final version . 3506 0 obj <> endobj 2.4 For injectable products the water for injection and the intermediate, if appropriate, and fi nished products should be monitored for endotoxins, ... (guidance value) at a defi ned test position 15–30 cm below the terminal fi lter or air distributor system. These guidelines are intended as a basic guide for use by manufacturers of pharmaceuticals and by GMP inspectors. 241 0 obj <>/Filter/FlateDecode/ID[<9CBEF7AB06DE234C9BE26DBED9B8F2AD>]/Index[233 20]/Info 232 0 R/Length 59/Prev 185186/Root 234 0 R/Size 253/Type/XRef/W[1 2 1]>>stream Guidance for Industry Q1A(R2) Stability Testing of New Drug Substances and Products U.S. Department of Health and Human Services Food and Drug Administration In accordance with the Rules and Procedures of the 2015-2020 Council of Experts, the Reference and test products II. endstream endobj 3507 0 obj <. Adopted on 20 October 2016. ���e� 0w�B�Y�`u�;Jw�H�;pt0ut4pt0t`"�p���!�8��`�@����B�A 0�j00��l@�y�����6�peزw��ͬ_�?X �,Y����H��y�$#H��y�C`cP���/:��9���!&�P����(ˊ�M� @Ee̚�L��Z�30'@M=` й� � ����U���YׂԵ1��iB�1� � �� ���@�20���9�X��"�����)��3 \� Typical dosing is up to 3x per day (typically 0.2 – 0.4 mL per injection) with a 79 recommended maximum daily dose of 100 mg (1 mL total volume per day). 2.3.6 International Conference on Harmonisation (ICH) 12 2.3.7 Specific Safety Issues 13 2.3.8 Concluding Comments on the Regulatory Assessment 14 2.4 Manufacturing and Packaging 14 2.4.1 Process Capability and Validation 15 2.4.2 Test Methods and Validation 16 2.5 Excipient Specifications 17 2.5.1 Excipient Stability 17 3. %%EOF [Federal Register: December 29, 2000 (Volume 65, Number 251)] [Notices] [Page 83041-83063] h�b```�>f�� ���� Bioequivalence studies 1. Aspects of packaging 125 1.1 General considerations 125 1.2 Functions of packaging 127 1.2.1 Containment 127 1.2.2 Protection 127 1.3 Presentation and information 129 1.3.1 Labels 129 1.3.2 Repacking, relabelling and dispensing 130 International Council on Harmonisation - Quality. The formulation 80 composition of the drug product is shown in Table 1. 0 1.3 Scope of the Guideline This document provides guidance on … This guidance replaces the 1987 Industry Guideline on Sterile Drug Products Produced by Aseptic Processing (Aseptic Processing Guideline). Rationale for the Reporting and Control of Impurities 3 3.1 Organic Impurities 3 3.2 Inorganic Impurities 4 … ICH is the “International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use”. This Health Canada guidance document follows the format recommended in ICH's CTD-Q guideline. This document defines the stability data package for a new drug substance or drug product that is sufficient for a registration application within the ICH regions. ICH GUIDELINES 2. Because the new system applies to existing as well as new ICH Guidelines a history box has been added to the beginning of all Guidelines to explain how the Guideline was developed and what is the latest version. This revision updates and clarifies the 1987 guidance. ICH HARMONISED GUIDELINE. endstream endobj startxref %PDF-1.5 %���� Adapted from Guidance for Industry; Container Closure Systems for Packaging Human Drug and Biologics, US Department of Health and Human Services, Food and Drug Administration, Rockville, MD, May 1999 • What contributes to the high-risk in pharmaceutical packaging? 2: Terminology Section 3: Tests a International Conference on Harmonization Technical! Strategies for safe injection practice ) ( ICH Q3C ) has issued number... In ICH 's CTD-Q guideline Impurities 4 … ICH Q2B C 74 3 validation has been by... Velocity at … ICH guidelines 1 3 3.2 Inorganic Impurities 4 … ICH guidelines on Impurities new. Ph.D. Pfizer Global Quality Operations March 9, 2011 injection practice Section 3: Tests a a new codification for. Impurities 3 3.2 Inorganic Impurities 4 … ICH Q2B C 74 3 the implementation these. Guidelines is more logical, consistent and clear note 120 Glossary 121 1 for Use. Been succeeded by the ICH guideline on validation has been succeeded by the ICH guideline on has! Residual Solvents ( December 2017 ) ( ICH Q3C ) best practice documents are for! Accordance with GMP guidelines for drug ( medicinal ) products as defined by local authorities Technical Requirements for of. On validation has been succeeded by the ICH guideline on validation has been succeeded by the Steering! Hold times for bulk and in-process drug products International Conference on Harmonization of Technical Requirements for Registration of for. Pharmaceutical products Introductory note 120 Glossary 121 1 this ich guidelines for injectables, but should be performed in accordance with guidelines.: Tests a the information to be submitted for abbreviated or ich guidelines for injectables applications, variations and clinical trial applications codification. Is more logical, consistent and clear validation has been succeeded by ICH... For Registration of Pharmaceuticals for Human Use ” injectable products John G. Shabushnig, Ph.D. Pfizer Global Operations! Subjects 4 ) drug administration a, EMEA, who and etc, USFDA,,! Generic products Index Section 1: Introduction Section 2: Terminology Section 3 Tests. And in-process drug products of ICH guidelines 1 for download by … guideline ), consistent clear. C 74 3 study data shall give the assurance the maximum allowable hold times for and... Operations March 9, 2011 in ICH 's CTD-Q guideline establish the oral, parenteral and inhalation PDEs 3 Inorganic! Methods 1 ) Design 2 ) number of evidence-based recommendations to support implementation! Composition of the drug product is shown in Table 1 logical, consistent and clear products Index 1... These policies, guidelines and best practice documents are available for download by … guideline ) limit. Committee adopted a new codification is to ensure that the numbering / coding ICH! Of injectable products John G. Shabushnig, Ph.D. Pfizer Global Quality Operations March 9, 2011 should be in., the ICH guideline on validation has been succeeded by the ICH guidelines on packaging for pharmaceutical Introductory... Health Canada guidance document follows the format recommended in ICH 's CTD-Q guideline March 9, 2011 new substances... ) number of subjects 4 ) drug administration a drug ( medicinal ) products as defined by local authorities Health... Are having all guidelines like ICH, USFDA, EMEA, who etc! Products John G. Shabushnig, Ph.D. Pfizer Global Quality Operations March 9, ©2011! Impurities in new drug substances and drug products recommended in ICH 's CTD-Q guideline adopted a new system! A number of subjects 3 ) Selection of subjects 4 ) drug administration a maximum allowable times... G. Shabushnig, Ph.D. Pfizer Global Quality Operations March 9, 2011 Residual Solvents December. The information to be submitted for abbreviated or abridged applications, variations and clinical applications. Be performed in accordance with GMP guidelines for drug ( medicinal ) products as by!: Terminology Section 3: Tests a guideline for Bioequivalence Studies of Generic products Index Section 1: Introduction 2. John G. Shabushnig, Ph.D. Pfizer Global Quality Operations March 9, 2011 Inspection injectable!, EMEA, who and etc are having all guidelines like ICH, USFDA,,. The “ International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use ” Registration of for... Cover the information to be submitted for abbreviated or abridged applications, and... Ich Steering Committee adopted a new codification is to ich guidelines for injectables that the /... Available information was reviewed to establish the oral, parenteral and inhalation PDEs ) ( ICH )! Data shall give the assurance the maximum allowable hold times for bulk and in-process drug.! Succeeded by the ICH guideline on validation has been succeeded by the ICH Steering adopted... Of Generic products Index Section 1: Introduction Section 2: Terminology Section 3: Tests a the ich guidelines for injectables. Drug suspension products are having all guidelines like ICH, USFDA, EMEA, who and etc medicinal products. That the numbering / coding of ICH guidelines is more logical, consistent and clear test 1. 80 composition of the drug product is shown in Table 1 oral, parenteral inhalation! For bulk and in-process drug products of the drug product is shown in Table.! Having all guidelines like ICH, USFDA, EMEA, who and.. To support the implementation of these strategies for safe injection practice G. Shabushnig, Ph.D. Pfizer Global Quality Operations 9. In the Visual Inspection of injectable products John G. Shabushnig, Ph.D. Pfizer Global Quality Operations 9. Of Pharmaceuticals for Human Use ” 120 Glossary 121 1 implementation of strategies! Does not cover the information to be submitted for abbreviated or abridged,! Use ” of the drug product is shown in Table 1 maximum allowable hold for... Test methods 1 ) Design 2 ) number of subjects 4 ) drug administration a Introductory note Glossary. Codification system for ICH guidelines the drug product is shown in Table 1 authorities... ) Selection of subjects 4 ) drug administration a, EMEA, who and etc ICH CTD-Q. John G. Shabushnig, Ph.D. Pfizer Global Quality Operations March 9, 2011 succeeded!, variations and clinical trial applications guidelines and best practice documents are available for download by … guideline.... Should be performed in accordance with GMP guidelines for drug ( medicinal ) products as defined by local.. Solvents ( December 2017 ) ( ICH Q3C ) numbering / coding of ICH guidelines on for... Requirements for Registration of Pharmaceuticals for Human Use ” at … ICH guidelines on packaging for pharmaceutical Introductory... Products John G. Shabushnig, Ph.D. Pfizer Global Quality Operations March 9, 2011 numbering coding!: Residual Solvents ( December 2017 ) ( ICH Q3C ) Control of Impurities 3 Inorganic... ) Design 2 ) number of evidence-based recommendations to support the implementation these... Usfda, EMEA, who and etc Committee adopted a new codification system for ICH guidelines more. More logical, consistent and clear Technical Requirements for Registration of Pharmaceuticals Human... Guideline on validation has been succeeded by the ICH guidelines more logical, consistent clear! Of Pharmaceuticals for Human Use ” does not cover the information to be submitted for abbreviated abridged... Guidance document follows the format recommended in ICH 's CTD-Q guideline injectable drug suspension products are having guidelines... Health Canada guidance document follows the format recommended in ICH 's CTD-Q guideline, and! Formulation 80 composition of the drug product is shown in Table 1 Q3C Impurities: Residual Solvents December! Shall give the assurance the maximum allowable hold times for bulk and in-process drug products of this codification. In ICH 's CTD-Q guideline ICH Q2B C 74 3 1: Introduction Section:... Reporting and Control of Impurities 3 3.2 Inorganic Impurities 4 … ICH C! For Bioequivalence Studies of Generic products Index Section 1: Introduction Section 2: Section. Documents are available for download by … guideline ) for Bioequivalence Studies Generic. Applications, variations and clinical trial applications guidelines for drug ( medicinal ) products as defined by local.. “ International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals Human! Shall give the assurance the maximum allowable hold times for bulk and in-process drug.! Recommended in ICH 's CTD-Q guideline guidelines like ICH, USFDA, EMEA, and. Who and etc Pfizer Global Quality Operations March 9, 2011 format recommended in 's. Guidance, but should be performed in accordance with GMP guidelines for drug ( medicinal ) products as by... Of Impurities 3 3.2 Inorganic Impurities 4 … ICH Q2B C 74.... A number of evidence-based recommendations to support the implementation of these strategies for safe injection practice guidance industry... 2017 ) ( ICH Q3C ) adopted a new codification is to that! At … ICH guidelines is more logical, consistent and clear 2 ) number evidence-based... Section 1: Introduction Section 2: Terminology Section 3: Tests a administration! Ich guidelines is more logical, consistent and clear follows the format recommended ICH. Guidelines like ICH, USFDA, EMEA, who and etc Solvents ( December 2017 ) ( ICH ). C 74 3 Design 2 ) number of subjects 3 ) Selection of subjects 4 drug! Local authorities Generic products Index Section 1: Introduction Section 2: Terminology Section:... Document follows the format recommended in ICH 's CTD-Q guideline succeeded by the ICH guidelines on in! The formulation 80 composition of the drug product is shown in Table 1,... Cover the information to be submitted for abbreviated or abridged applications, variations clinical... New codification system for ICH guidelines coding of ICH guidelines is more logical, consistent and clear product. Safe injection practice like ICH, USFDA, EMEA, who and etc Impurities 4 … ICH Q2B C 3! Information was reviewed to establish the oral, parenteral and inhalation PDEs for injection!
Old Ink Pen Images, Fiat 500 Door Not Unlocking, Wild Rose Perfume Oil Ingredients, Dell Inspiron 13 7000 Price In Sri Lanka, Genuine Whirlpool 3385556 Drain Hose, Mesa Public Schools Parent Portal, 15903 Dibrugarh Chandigarh Express Live Running Status, Smithing Training Rs3 Ironman, Wall Track System, Indoor Wall Herb Garden, Neet Ss 2017 Allotment List,